ICAM1 and neoplasm: Further studies into mechanisms of tumor tissue penetration, as regulated by CD54 or otherwise, will prove to be pivotal for understanding how and why constructs such as bPNMs can capitalize on this unique facet of biomimetic nanotechnology.